Get the Stockscreener App
3.82
0.00%
+0.00
After Hours:
3.84
0.02
+0.52%
Harvard Bioscience Inc. Stock (HBIO) Forecast
The Harvard Bioscience Inc. (HBIO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.9638, representing a +29.94% increase from the current price of $3.82. The highest analyst price target is $5.4103, and the lowest is $4.5173.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HBIO Price Target
Average 5.021
(+31.44% Upside)
Is Harvard Bioscience Inc. (HBIO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 43.58 | Neutral |
| STOCH(9,6) | 29.24 | Neutral |
| STOCHRSI(14) | 51.33 | Neutral |
| MACD(12,26) | -0.161 | Sell |
| ADX(14) | 32.75 | Sell |
| William %R | -62.38 | Neutral |
| CCI(14) | -9.071 | Neutral |
Buy: 0
Sell: 2
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.731
Buy
|
3.8074
Buy
|
| MA20 |
4.0398
Sell
|
3.9375
Sell
|
| MA50 |
4.1911
Sell
|
4.157
Sell
|
| MA100 |
4.4987
Sell
|
4.3132
Sell
|
| MA200 |
4.4339
Sell
|
4.3551
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, HBIO could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on HBIO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 43.58 indicates that HBIO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 29.24 indicates that HBIO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 51.33 indicates that HBIO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 32.75 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -9.071 indicates that HBIO is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term HBIO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Harvard Bioscience Inc. financial reports and earnings history, Harvard Bioscience Inc. (HBIO) stock could reach $8.9965 by 2030, $14.18 by 2040 and $22.98 by 2050. See the projected annual prices until 2050 of the Harvard Bioscience Inc. stock below:
- Harvard Bioscience Inc. (HBIO) is expected to reach an average price of $12.03 in 2035, with a high prediction of $12.30 and a low estimate of $11.68. This indicates an $214.84% rise from the last recorded price of $3.82.
- Harvard Bioscience Inc. (HBIO) stock is projected to chart a bullish course in 2040, with an average price target of $14.10, representing an $269.05% surge from its current level. The forecast ranges from a conservative $13.38 to a sky-high $14.18.
- Our analysts predict Harvard Bioscience Inc. (HBIO) to jump 350.09% by 2045, soaring from $16.95 to an average price of $17.19, potentially reaching $17.63. While $16.95 is the low estimate, the potential upside is significant.
- Harvard Bioscience Inc. (HBIO) stock is expected to climb by 2050, reaching an average of $22.32, a $484.40% jump from its current level. However, a wide range of estimates exists, with high and low targets of $22.98 and $21.80, respectively, highlighting the market's uncertainty.
Harvard Bioscience Inc. Stock (HBIO) Year by Year Forecast
Harvard Bioscience Inc. Stock (HBIO) Price Forecast for 2024
Our forecast for HBIO stock price in 2024 now indicates an average price target of $5.4816 with a high forecast of $7.0119 and a low forecast of $3.9512. The average prediction reflects an increase of +43.50% from the last recorded price of $3.82.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $4.6473 | $4.5173 | $5.4103 | +21.66% |
| July, 2024 | $4.3306 | $4.3236 | $4.7179 | +13.37% |
| August, 2024 | $4.9332 | $3.9512 | $5.1226 | +29.14% |
| September, 2024 | $4.9565 | $4.6896 | $5.2809 | +29.75% |
| October, 2024 | $5.5592 | $4.7922 | $5.9435 | +45.53% |
| November, 2024 | $5.3319 | $5.1219 | $5.7105 | +39.58% |
| December, 2024 | $5.5102 | $4.9445 | $5.5496 | +44.25% |
Harvard Bioscience Inc. Stock (HBIO) Price Forecast for 2025
Harvard Bioscience Inc. Stock (HBIO) is expected to reach an average price of $5.6233 in 2025, with a high prediction of $7.1987 and a low estimate of $4.0478. This indicates an +47.21% rise from the last recorded price of $3.82.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $5.3678 | $5.3328 | $5.9408 | +40.52% |
| February, 2025 | $5.6755 | $5.3285 | $5.6855 | +48.57% |
| March, 2025 | $5.6138 | $5.4511 | $5.8809 | +46.96% |
| April, 2025 | $5.3665 | $5.1008 | $6.0908 | +40.48% |
| May, 2025 | $4.9191 | $4.0478 | $5.4521 | +28.77% |
| June, 2025 | $5.4474 | $4.7348 | $5.5361 | +42.60% |
| July, 2025 | $5.3701 | $4.7788 | $5.6144 | +40.58% |
| August, 2025 | $5.7827 | $5.2858 | $5.9185 | +51.38% |
| September, 2025 | $6.1311 | $5.4384 | $6.5354 | +60.50% |
| October, 2025 | $6.4437 | $5.7189 | $7.1987 | +68.68% |
| November, 2025 | $6.0064 | $5.9464 | $6.5694 | +57.23% |
| December, 2025 | $5.8947 | $5.5734 | $6.1246 | +54.31% |
Harvard Bioscience Inc. Stock (HBIO) Price Forecast for 2026
The predicted value for Harvard Bioscience Inc. (HBIO) in 2026 is set at an average of $8.8441. Estimates vary from a peak of $11.87 to a trough of $5.8217, indicating an +131.52% surge from the present price of $3.82.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $6.2473 | $5.8217 | $6.356 | +63.54% |
| February, 2026 | $6.76 | $6.233 | $7.2843 | +76.96% |
| March, 2026 | $6.9983 | $6.6357 | $7.4927 | +83.20% |
| April, 2026 | $7.331 | $6.9853 | $7.5853 | +91.91% |
| May, 2026 | $7.5636 | $7.2966 | $8.168 | +98.00% |
| June, 2026 | $8.4919 | $6.845 | $10.09 | +122.30% |
| July, 2026 | $9.9846 | $8.2276 | $10.14 | +161.38% |
| August, 2026 | $10.19 | $9.4703 | $10.83 | +166.83% |
| September, 2026 | $10.24 | $9.8386 | $10.91 | +167.95% |
| October, 2026 | $11.26 | $10.17 | $11.63 | +194.72% |
| November, 2026 | $11.58 | $10.31 | $11.87 | +203.05% |
| December, 2026 | $11.38 | $10.92 | $11.62 | +197.88% |
Harvard Bioscience Inc. Stock (HBIO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Harvard Bioscience Inc. (HBIO) is $9.1251, with a high forecast of $11.59 and a low forecast of $6.6554. This indicates an +138.88% increase from the last price of $3.82.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $10.15 | $10.09 | $11.59 | +165.76% |
| February, 2027 | $10.13 | $9.5388 | $10.48 | +165.30% |
| March, 2027 | $10.11 | $9.9628 | $11.43 | +164.73% |
| April, 2027 | $10.08 | $9.5843 | $10.46 | +163.76% |
| May, 2027 | $9.0238 | $8.7438 | $10.61 | +136.23% |
| June, 2027 | $8.9565 | $8.7695 | $9.4715 | +134.46% |
| July, 2027 | $8.7291 | $8.2978 | $9.0121 | +128.51% |
| August, 2027 | $9.5674 | $8.6748 | $9.7848 | +150.46% |
| September, 2027 | $8.5801 | $8.4601 | $9.8331 | +124.61% |
| October, 2027 | $7.1327 | $6.7315 | $9.0657 | +86.72% |
| November, 2027 | $7.2311 | $6.6554 | $7.8847 | +89.29% |
| December, 2027 | $7.0837 | $6.9037 | $7.4037 | +85.44% |
Harvard Bioscience Inc. Stock (HBIO) Price Forecast for 2028
In 2028, Harvard Bioscience Inc. (HBIO) is projected to reach an average price of $7.7754, with a high projection of $9.9899 and a low estimate of $5.561. This indicates an +103.55% rise from the last price of $3.82.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $6.712 | $6.562 | $7.2807 | +75.71% |
| February, 2028 | $6.6447 | $6.5777 | $6.9477 | +73.94% |
| March, 2028 | $5.9573 | $5.7717 | $6.7254 | +55.95% |
| April, 2028 | $6.22 | $5.663 | $6.272 | +62.83% |
| May, 2028 | $6.1183 | $5.6413 | $6.3057 | +60.17% |
| June, 2028 | $6.311 | $5.561 | $6.5384 | +65.21% |
| July, 2028 | $6.5693 | $5.9866 | $6.6093 | +71.97% |
| August, 2028 | $6.6519 | $6.515 | $6.9263 | +74.13% |
| September, 2028 | $6.3246 | $6.0746 | $6.6276 | +65.57% |
| October, 2028 | $8.6129 | $6.0903 | $8.8329 | +125.47% |
| November, 2028 | $9.3156 | $8.2086 | $9.9899 | +143.86% |
| December, 2028 | $9.4582 | $8.8012 | $9.7369 | +147.60% |
Harvard Bioscience Inc. Stock (HBIO) Price Forecast for 2029
The 2029 price forecast for Harvard Bioscience Inc. Stock (HBIO) is $8.6316 on average, with a high prediction of $9.9452 and a low estimate of $7.318. This represents an +125.96% increase from the previous price of $3.82.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $9.4465 | $8.9596 | $9.9452 | +147.29% |
| February, 2029 | $8.4292 | $8.3992 | $9.6422 | +120.66% |
| March, 2029 | $8.1119 | $7.7662 | $8.7349 | +112.35% |
| April, 2029 | $7.9202 | $7.8565 | $8.4445 | +107.33% |
| May, 2029 | $8.1328 | $7.8458 | $8.4572 | +112.90% |
| June, 2029 | $7.8755 | $7.6755 | $8.3898 | +106.16% |
| July, 2029 | $9.1238 | $7.7911 | $9.2038 | +138.84% |
| August, 2029 | $7.6913 | $7.48 | $9.2001 | +101.34% |
| September, 2029 | $7.5266 | $7.4566 | $8.1253 | +97.03% |
| October, 2029 | $8.9333 | $7.318 | $8.9633 | +133.86% |
| November, 2029 | $8.3536 | $8.2373 | $9.0546 | +118.68% |
| December, 2029 | $8.8202 | $8.2899 | $9.3639 | +130.90% |
Harvard Bioscience Inc. Stock (HBIO) Price Forecast for 2030
Harvard Bioscience Inc. Stock (HBIO) is expected to reach an average price of $7.6895 in 2030, with a high forecast of $8.9965 and a low forecast of $6.3825. This signifies an +101.30% surge from the last price of $3.82.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.1905 | $7.1905 | $8.9965 | +88.23% |
| February, 2030 | $6.7958 | $6.7858 | $7.3019 | +77.90% |
| March, 2030 | $6.7561 | $6.7322 | $6.9885 | +76.86% |
| April, 2030 | $7.2778 | $6.3825 | $7.5665 | +90.52% |
| May, 2030 | $7.4331 | $7.1491 | $7.7518 | +94.58% |
| June, 2030 | $8.0584 | $7.2744 | $8.4384 | +110.95% |
| July, 2030 | $7.805 | $7.6437 | $8.2211 | +104.32% |
| August, 2030 | $8.0604 | $7.489 | $8.0998 | +111.00% |
| September, 2030 | $8.007 | $7.9057 | $8.4967 | +109.61% |
| October, 2030 | $8.3023 | $7.9783 | $8.4223 | +117.34% |
| November, 2030 | $8.2376 | $8.125 | $8.4991 | +115.64% |
| December, 2030 | $7.5342 | $7.3542 | $8.7316 | +97.23% |
0.69%
0.07%
Cap:
|
Volume (24h):